Loading data
CANFNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 405 k USD | 674 k USD | 743 k USD | 810 k USD | 853 k USD |
| Research and development expense | 6.69 m USD | 5.76 m USD | 5.98 m USD | 7.76 m USD | 9.85 m USD |
| Selling, general and administrative expense | — | — | — | 263 k USD | 466 k USD |
| Operating profit | -9.95 m USD | -8.13 m USD | -8.2 m USD | -10.1 m USD | -12.84 m USD |
| Profit before tax | -9.83 m USD | -7.88 m USD | -7.63 m USD | -10.17 m USD | -12.62 m USD |
| Net income (reported basis) | -9.83 m USD | -7.88 m USD | -7.63 m USD | -10.17 m USD | -12.62 m USD |
| Basic earnings per share | -5.97 USD/share | -10.86 USD/share | -17.92 USD/share | -0.01 USD/share | -0.03 USD/share |
| Diluted earnings per share | -5.97 USD/share | -10.86 USD/share | -17.92 USD/share | -0.01 USD/share | -0.03 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.